Cargando…

Severe myocarditis due to influenza A(H1N1)pdm09 viral infection in a young woman successfully treated with intravenous zanamivir: A case report

In patients with influenza‐related myocarditis, prompt diagnosis and treatment are important. Intravenous zanamivir can be an alternative to oral oseltamivir, especially in severe cases and when drug intestinal malabsorption is suspected or proven.

Detalles Bibliográficos
Autores principales:	Mazzitelli, Maria, Garofalo, Eugenio, Bruni, Andrea, Barreca, Giorgio Settimo, Quirino, Angela, Giancotti, Aida, Serapide, Francesca, Indolfi, Ciro, Matera, Giovanni, Navalesi, Paolo, Trecarichi, Enrico Maria, Torti, Carlo, Longhini, Federico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935647/ https://www.ncbi.nlm.nih.gov/pubmed/31893053 http://dx.doi.org/10.1002/ccr3.2499

Ejemplares similares

Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series
por: Torti, Carlo, et al.
Publicado: (2019)

Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4
por: Marascio, Nadia, et al.
Publicado: (2019)

Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience
por: Quirino, Angela, et al.
Publicado: (2022)

Multidisciplinary approach to a septic COVID‐19 patient undergoing veno‐venous extracorporeal membrane oxygenation and receiving thoracic surgery
por: Bruni, Andrea, et al.
Publicado: (2021)

Phylogenetic and Molecular Analyses of More Prevalent HCV1b Subtype in the Calabria Region, Southern Italy
por: Marascio, Nadia, et al.
Publicado: (2021)

Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital
por: Scaglione, Vincenzo, et al.
Publicado: (2022)

Evaluation of IL-35, as a Possible Biomarker for Follow-Up after Therapy, in Chronic Human Schistosoma Infection
por: Marascio, Nadia, et al.
Publicado: (2023)

Is the Pendulum of Antimicrobial Drug Resistance Swinging Back after COVID-19?
por: Serapide, Francesca, et al.
Publicado: (2022)

Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19
por: Russo, A., et al.
Publicado: (2023)

Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014
por: Trebbien, Ramona, et al.
Publicado: (2017)

Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report
por: Pelle, Maria Chiara, et al.
Publicado: (2020)

Intravenous zanamivir for influenza myocarditis and enteral malabsorption
por: Jahns, Fritz-Patrick, et al.
Publicado: (2018)

Discussion on critical points for a tailored therapy to cure hepatitis C virus infection
por: Marascio, Nadia, et al.
Publicado: (2019)

Spontaneous and Severe Haematomas in Patients with COVID-19 on Low- Molecular-Weight Heparin for Paroxysmal Atrial Fibrillation
por: Mazzitelli, Maria, et al.
Publicado: (2020)

Microbiological and Clinical Findings of SARS-CoV-2 Infection after 2 Years of Pandemic: From Lung to Gut Microbiota
por: Russo, Alessandro, et al.
Publicado: (2022)

Increase of Vascular Endothelial Growth Factor and Decrease of MCP-1 and Some Updated Epidemiology Aspects of Cystic Echinococcosis Human Cases in Calabria Region
por: Matera, Giovanni, et al.
Publicado: (2018)

I223R Mutation in Influenza A(H1N1)pdm09 Neuraminidase Confers Reduced Susceptibility to Oseltamivir and Zanamivir and Enhanced Resistance with H275Y
por: LeGoff, Jérome, et al.
Publicado: (2012)

A case report of pneumomediastinum in a COVID‐19 patient treated with high‐flow nasal cannula and review of the literature: Is this a “spontaneous” complication?
por: Cancelliere, Anna, et al.
Publicado: (2021)

Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy
por: De Marco, Carmela, et al.
Publicado: (2022)

Eleven-Year Distribution Pattern of Hepatitis C Virus in Southern Italy
por: Marascio, Nadia, et al.
Publicado: (2012)

Whole-genome analysis of SARS-CoV-2 in a 2020 infection cluster in a nursing home of Southern Italy
por: De Marco, Carmela, et al.
Publicado: (2022)

Potential implications of SARS-CoV-2 epidemic in Africa: where are we going from now?
por: Torti, Carlo, et al.
Publicado: (2020)

A Rare Complication of Ascariasis: A Case of Acute Interstitial Nephritis
por: Carullo, Nazareno, et al.
Publicado: (2023)

Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19
por: Mazzitelli, Maria, et al.
Publicado: (2020)

Virological and Clinical Outcome of DAA Containing Regimens in a Cohort of Patients in Calabria Region (Southern Italy)
por: Scaglione, Vincenzo, et al.
Publicado: (2020)

Predictivity of frontal QRS-T angle for death in COVID-19 patients may differ by age
por: Tassone, Bruno, et al.
Publicado: (2022)

In vitro Activity of Cefiderocol Against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: a Single Center Experience
por: Quirino, Angela, et al.
Publicado: (2023)

Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis
por: Bruni, Andrea, et al.
Publicado: (2020)

The Role of the Microbiota Gut–Liver Axis during HCV Chronic Infection: A Schematic Overview
por: Marascio, Nadia, et al.
Publicado: (2022)

Zanamivir should be inhaled, not nebulised
por: Eagel, Barry A
Publicado: (2010)

Characteristics, Management, and Outcomes of Elderly Patients with Diabetes in a Covid-19 Unit: Lessons Learned from a Pilot Study
por: Ricchio, Marco, et al.
Publicado: (2021)

Similarities, differences, and possible interactions between hepatitis E and hepatitis C viruses: Relevance for research and clinical practice
por: Marascio, Nadia, et al.
Publicado: (2022)

The Role of Gut Microbiota in the Clinical Outcome of Septic Patients: State of the Art and Future Perspectives
por: Marascio, Nadia, et al.
Publicado: (2023)

Influenza A(H1N1)pdm09 virus and asthma
por: Obuchi, Masatsugu, et al.
Publicado: (2013)

The hemagglutinin of the influenza A(H1N1)pdm09 is mutating towards stability
por: Castelán-Vega, Juan A, et al.
Publicado: (2014)

Development of PREDAC-H1pdm to model the antigenic evolution of influenza A/(H1N1) pdm09 viruses
por: Liu, Mi, et al.
Publicado: (2023)

Analysis of Adaptation Mutants in the Hemagglutinin of the Influenza A(H1N1)pdm09 Virus
por: Jiménez-Alberto, Alicia, et al.
Publicado: (2013)

Neurological events related to influenza A (H1N1) pdm09
por: Cárdenas, Graciela, et al.
Publicado: (2014)

The 2015 influenza A (H1N1) pdm09 outbreak in India
por: Murhekar, Manoj, et al.
Publicado: (2016)

Influenza A(H1N1)pdm09 and postpandemic influenza in Lithuania
por: Ambrozaitis, Arvydas, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0egibifmv4i5tstjvmj6gu6tg0